16
ICD10 code of Essential Thrombocythemia and ICD9 code
What is the ICD10 code for Essential Thrombocythemia? And the ICD9 code for Essential Thrombocythemia?
Essential Thrombocythemia is a blood disorder characterized by the overproduction of platelets in the bone marrow. The ICD-10 code for Essential Thrombocythemia is D47.3. In the previous coding system, the ICD-9 code for this condition was 238.71. These codes are used for medical billing and classification purposes.
Essential Thrombocythemia (ET) is a rare chronic blood disorder characterized by the overproduction of platelets in the bone marrow. Platelets are responsible for blood clotting, and an excessive amount can lead to abnormal clotting or bleeding. The International Classification of Diseases, Tenth Revision (ICD-10) provides a specific code for this condition.
The ICD-10 code for Essential Thrombocythemia is D47.3. This code falls under the category of "Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic, and related tissue." The code D47.3 is used to identify and classify cases of Essential Thrombocythemia in medical records, billing, and statistical purposes.
In contrast, the ICD-9 code for Essential Thrombocythemia was 238.79. However, it's important to note that the ICD-9 system is no longer in use, as it has been replaced by the more comprehensive ICD-10 coding system. The transition from ICD-9 to ICD-10 took place on October 1, 2015, in order to provide more specific and detailed codes for various medical conditions.
Essential Thrombocythemia is a condition that requires careful monitoring and management by healthcare professionals. It can lead to complications such as blood clots, stroke, or bleeding disorders. Treatment options may include medications to control platelet production, periodic phlebotomy (blood removal), or the use of blood thinners to prevent clotting.
In summary, the ICD-10 code for Essential Thrombocythemia is D47.3, while the ICD-9 code was 238.79. These codes serve as standardized identifiers for this rare blood disorder, allowing healthcare providers to accurately document and classify cases of Essential Thrombocythemia for effective management and research purposes.
The ICD-10 code for Essential Thrombocythemia is D47.3. This code falls under the category of "Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic, and related tissue." The code D47.3 is used to identify and classify cases of Essential Thrombocythemia in medical records, billing, and statistical purposes.
In contrast, the ICD-9 code for Essential Thrombocythemia was 238.79. However, it's important to note that the ICD-9 system is no longer in use, as it has been replaced by the more comprehensive ICD-10 coding system. The transition from ICD-9 to ICD-10 took place on October 1, 2015, in order to provide more specific and detailed codes for various medical conditions.
Essential Thrombocythemia is a condition that requires careful monitoring and management by healthcare professionals. It can lead to complications such as blood clots, stroke, or bleeding disorders. Treatment options may include medications to control platelet production, periodic phlebotomy (blood removal), or the use of blood thinners to prevent clotting.
In summary, the ICD-10 code for Essential Thrombocythemia is D47.3, while the ICD-9 code was 238.79. These codes serve as standardized identifiers for this rare blood disorder, allowing healthcare providers to accurately document and classify cases of Essential Thrombocythemia for effective management and research purposes.
Diseasemaps
ICD-9-CM 238.71 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 238.71 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Posted Aug 11, 2017 by Steve 2685
Thrombocytosis (or thrombocythemia) is the presence of high platelet counts in the blood, and can be either primary (also termed essential and caused by a myeloproliferative disease) or reactive (also termed secondary). Although often symptomless (particularly when it is a secondary reaction), it can predispose to thrombosis in some patients. Thrombocytosis can be contrasted with thrombocytopenia, a loss of platelets in the blood.
Posted Feb 7, 2019 by James 3550
